Novo Nordisk invests €134m in new company hq
Will house management and more than 1,000 employees
Novo Nordisk is investing around DKK1bn (€134m) in two new office buildings in Bagsværd, Denmark, consolidating a number of administrative functions currently scattered across the Copenhagen region.
The project is expected to create more than 300 jobs during the construction phase.
The new 8,800m2 office premises will house Novo Nordisk’s top management, 1,100 administrative staff and a number of shared facilities.
Groundbreaking will take place in October, and the new corporate centre is expected to be ready for occupancy at the end of 2013.
‘The new buildings will give our employees the best conditions for interacting across functional divides and with our colleagues abroad,’ said Lars Rebien Sørensen, president and ceo of Novo Nordisk.
The insulin molecule with its contoured spiral shape was a key source of inspiration for Henning Larsen Architects. The new building will combine white materials with Nordic stone and wood. The aim was to create a dynamic work setting closely allied with external natural features.
The buildings will feature low energy consumption with the aid of sensors, light and ventilation, and will meet the 2015 energy requirements for new buildings.
Around 14,000 of Novo Nordisk’s 32,000 employees work in Denmark.